CorVista Health to Present New Data on Non-Invasive Point of Care Test for Ischemia with Non-Obstructive Coronary Arteries Using Machine Learning at ACC.26
CorVista Health today announced the upcoming poster presentation of new data on its non-invasive point of care test for ischemia with non-obstructive coronary arteries (INOCA) – a common condition, particularly in women, where patients experience cardiovascular symptoms despite having no flow-limiting blockages in their major epicardial arteries – using machine learning at the American College of Cardiology’s Annual Scientific Session (ACC.26), taking place March 28-30, 2026, in New Orleans, LA.
CorVista Health Named MedTech Outlook Editor's Choice for MedTech Startup for 2023
CorVista Health, Inc, a leading digital health company dedicated to improving cardiovascular disease diagnosis, is pleased to announce that it has been honored with the Editor’s Choice designation as the Top MedTech Startup for 2023 by MedTech Outlook.
Charles R. Bridges, M.D., Sc.D., Elected to the National Academy of Engineering Membership
CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the election of Dr. Charles Bridges to the National Academy of Engineering (NAE). In addition to Dr. Bridges, NAE President John L. Anderson announced 132 new members for 2022, bringing the total U.S. membership to 2,388 and international to 310.
